Dexmedetomidine protects against lipid peroxidation and erythrocyte deformability alterations in experimental hepatic ischemia reperfusion injury

Libyan Journal of Medicine

Volumn 7, Issue 1, 2012, Pages

  Arslan, Mustafa ^a   Çomu, Faruk Metin ^b   Küçük, Ayşegül ^c   Öztürk, Levent ^d   Yaylak, Faik ^c  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b KIRIKKALE UNIVERSITY   (Turkey)

^c DUMLUPINAR UNIVERSITY   (Turkey)

^d ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Dexmedetomidine; Erythrocyte deformability; Hepatic ischemia reperfusion injury; Lipid peroxidation; Malondialdehyde; Superoxide dismutase

Indexed keywords

DEXMEDETOMIDINE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME SYNTHESIS; ERYTHROCYTE DEFORMABILITY; LIPID PEROXIDATION; LIVER ISCHEMIA; MALE; NONHUMAN; RAT; REPERFUSION INJURY;

EID: 84864389201     PISSN: 19932820     EISSN: 18196357     Source Type: Journal    
DOI: 10.3402/ljm.v7i0.18185     Document Type: Article

References (30)

1. Siriussawakul A, Zaky A, Lang JD. Role of nitric oxide in hepatic ischemia-reperfusion injury. World J Gastroenterol. 2010; 16: 6079-6086.
2. Alchera E, Dal Ponte C, Imarisio C, Albano E, Carini R. Molecular mechanisms of liver preconditioning. World J Gastroenterol. 2010; 16: 6058-6067.
3. Yaylak F, Canbaz H, Caglikulekci M, Dirlik M, Tamer L, Ogetman Z, et al. Liver tissue inducible nitric oxide synthase (iNOS) expression and lipid peroxidation in experimental hepatic ischemia reperfusion injury stimulated with lipopoly-saccharide: the role of aminoguanidine. J Surg Res. 2008; 148: 214-223.
4. Bedirli N, Ofluoglu E, Kerem M, Utebey G, Alper M, Yilmazer D, et al. Hepatic energy metabolism and the differential protective effects of sevoflurane and isoflurane anesthesia in a rat hepatic ischemia-reperfusion injury model. Anesth Analg. 2008; 106: 830-837.
5. Grisham MB, Granger DN. Free radicals: reactive metabolites of oxygen as mediators of postischemic reperfusion injury. In: Martson A, Bulkley GB, Fiddian-Green RG, Haglung U, editors. Splanchnic ischemia and multiple organ failure. St. Louis: Mosby; 1989, pp. 135-144.
6. Peto K, Nemeth N, Brath E, Takacs IE, Baskurt OK, Meiselman HJ, et al. The effects of renal ischemia-reperfusion on hemor-heological factors: preventive role of allopurinol. Clin Hemor-heol Microcirc. 2007; 37: 347-358.
7. McCutcheon CA, Orme RM, Scott DA, Davies MJ, McGlade DP. A comparison of dexmedetomidine versus conventional therapy for sedation and hemodynamic control during carotid endarterectomy performed under regional anesthesia. Anesth Analg. 2006; 102: 668-675.
8. Ramsay MA, Luterman DL. Dexmedetomidine as a total intravenous anesthetic agent. Anesthesiology. 2004; 101: 787-790.
9. Maier CM, Sun GH, Kunis DM, Giffard RG, Steinberg GK. Neuroprotection by the N-methyl-D-aspartate receptor antagonist CGP 40116: in vivo and in vitro studies. JNeurochem. 1995; 65: 652-659.
10. Kocoglu H, Karaaslan K, Gonca E, Bozdogan O, Gulcu N. Preconditioning effects of dexmedetomidine on myocardial ischemia/reperfusion injury in rats. Curr Ther Res Clin Exp. 2008; 69: 150-158.
11. Kocoglu H, Ozturk H, Ozturk H, Yilmaz F, Gulcu N. Effect of dexmedetomidine on ischemia-reperfusion injury in rat kidney: a histopathologic study. Ren Fail. 2009; 31: 70-74.
12. Hoffman WE, Kochs E, Werner C, Thomas C, Albrecht RF. Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha 2-adrenergic antagonist atipamezole. Anesthesiology. 1991; 75: 328-332.
13. Snapir A, Posti J, Kentala E, Koskenvuo J, Sundell J, Tuunanen H, et al. Effects of low and high plasma concentrations of dexmedetomidine on myocardial perfusion and cardiac function in healthy male subjects. Anesthesiology. 2006; 105: 902-910.
14. Engelhard K, Werner C, Eberspacher E, Bachl M, Blobner M, Hildt E, et al. The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg. 2003; 96: 524-531.
15. Jaeschke H, Leamsters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology. 2003; 125: 1246-1257.
16. Marnett LJ. Lipid peroxidation-DNA damage by malondialde-hyde. Mutat Res. 1999; 424: 83-95.
17. Giakoustidis D, Papageorgiou G, Iliadis S, Giakoustidis A, Kostopoulou E, Kontos N, et al. The protective effect of alpha-tocopherol and GdCl3 against hepatic ischemia/reperfusion injury. Surg Today. 2006; 36: 450-456.
18. Muller R, Musikic P. Hemorheology in surgery: a review. Angiology 1987; 38: 581-592.
19. Simchon S, Jan KM, Chien S. Influence of reduced red cell deformability on regional blood flow. Am J Physiol. 1987; 253: H898-H903.
20. Zinchuk VV. Erythrocyte deformability: physiological aspects. Usp Fiziol Nauk. 2001; 32: 66-78.
21. Therond P, Bonnefont-Rousselot D, David-Spraul A, Conti M, Legrand A. Biomarkers of oxidative stress: an analytical approach. Curr Opin Clin Nutr Metab Care. 2000; 3: 373-384.
22. Kuypers FA. Red cell membrane damage. J Heart Valve Dis. 1998; 7: 387-395.
23. Sivilotti ML. Oxidant stress and haemolysis of the human erythrocyte. Toxicol Rev. 2004; 23: 169-188.
24. Mates JM, Perez-Gomez C, Castro IN. Antioxidant enzymes and human disease. Clin Biochem. 1999; 32: 595-603.
25. Yerer MB, Yapislar H, Aydogan S, Yalcin O, Baskurt O. Lipid peroxidation and deformability of red blood cells in experimental sepsis in rats: The protective effects of melatonin. Clin Hemorheol Microcirc. 2004; 30: 77-82.
26. Johnson F, Giulivi C. Superoxide dismutases and their impact upon human health. Mol Aspects Med. 2005; 26: 340-352.
27. Yagmurdur MC, Ozdemir A, Topaloglu S, Kilinc K, Ozenc A. Effects of alpha tocopherol and verapamil on liver and small bowel following mesenteric ischemia-reperfusion. Turk J Gastroenterol. 2002; 13: 40-46.
28. Granger DN, Korthuis RJ. Physiologic mechanisms of postischemic tissue injury. Annu Rev Physiol. 1995; 57: 311-332.
29. Hanci V, Erol B, Bektas S, Mungan G, Yurtlu S, Tokgoz H. Effect of dexmedetomidine on testicular torsion/detorsion damage in rats. Urol Int. 2010; 84: 105-111.
30. Yagmurdur H, Ozcan N, Dokumaci F, Kilinc K, Yilmaz F, Basar H. Dexmedetomidine reduces the ischemia-reperfusion injury markers during upper extremity surgery with tourniquet. J Hand Surg Am. 2008; 33: 941-947.